Palladiem, LLC has submitted its latest 13F-HR filing, revealing a total of 134 holdings valued at over $102 million as of September 30, 2026. This report is crucial as it provides insights into the firm’s investment strategy and positions within the financial services sector.

According to the filing, Palladiem's portfolio includes significant stakes in well-known companies such as Abbott Laboratories and Alphabet Inc. This diverse portfolio reflects the firm's approach to asset management and its commitment to navigating the complexities of the financial markets.

Background

Palladiem, LLC is a financial services firm based in Bryn Mawr, Pennsylvania. The company is classified under the SEC as an investment manager, and it has been actively filing 13F reports since its inception. The latest filing, dated November 9, 2026, follows a series of reports that detail its investment activities.

What the Filing Says

The filing indicates that Palladiem holds a total of 134 positions with a combined value of $102,203,063. Notably, the report states, "The total value of the holdings reflects our strategic investment approach and focus on long-term growth."

Impact

This filing may impact various stakeholders, including investors and competitors in the financial services sector. Investors will be keen to analyze Palladiem's strategies and holdings to gauge market trends, while competitors may adjust their strategies in response to Palladiem's investment choices.

What's Next

The filing does not say what happens next.